Antiplatelet medications are the centerpiece of most secondary prevention regimens in ischemic stroke. Three therapies are commonly used for this purpose: aspirin, clopidogrel, and a combination of ...
Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens — aspirin plus extended-release dipyridamole (ASA–ERDP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback